Literature DB >> 20493454

[The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney and prostate cancers].

Y Neuzillet1, S Négrier, K Fizazi, G Pignot, A Benchikh El Fegoun, J Guillotreau, S Culine.   

Abstract

The collaboration of the Association Française d'Urologie (AFU) and of the Groupe d'Etude des Tumeurs Uro-Genital (GETUG) has lead to increase more and more the credibility of French clinical trials in onco-urology. These trials are on the same level ast North American or European studies. The involvement of urologists is essential. Therefore it seemed necessary to do an update on ongoing trials to further increase recruitment from all practitioners involved in onco-urology.

Entities:  

Mesh:

Year:  2010        PMID: 20493454     DOI: 10.1016/S1166-7087(10)70035-X

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  3 in total

1.  Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials.

Authors:  Boris Campillo-Gimenez; Camille Buscail; Oussama Zekri; Brigitte Laguerre; Elisabeth Le Prisé; Renaud De Crevoisier; Marc Cuggia
Journal:  Trials       Date:  2015-01-16       Impact factor: 2.279

2.  Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.

Authors:  Olivier Riou; Pauline Regnault de la Mothe; David Azria; Norbert Aillères; Jean-Bernard Dubois; Pascal Fenoglietto
Journal:  J Appl Clin Med Phys       Date:  2013-07-08       Impact factor: 2.102

3.  Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center.

Authors:  Olivier Riou; Pascal Fenoglietto; Benoit Laliberté; Cathy Menkarios; Carmen Llacer Moscardo; Meng Huor Hay; Norbert Ailleres; Jean-Bernard Dubois; Xavier Rebillard; David Azria
Journal:  ISRN Urol       Date:  2012-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.